Examining the efficacy of a Home-Based exercise training intervention for wheelchair users with multiple sclerosis
NCT ID NCT07891520
First seen Oct 23, 2026 · Last updated Oct 23, 2026
Summary
The purpose of this study is to assess changes in the outcome of exercise behavior between the SPIN exercise-training condition and the WEllness for Longevity Living (WELL) attention/contact wellness control condition and to examine differences in exercise behavior, functioning, disability, and health between the SPIN and WELL conditions
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jan 2027
An estimate. Start dates often move.
- Expected to finish
-
Feb 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosis of multiple sclerosis (MS). * Self-reported use of a wheelchair (manual wheelchair, power wheelchair, or scooter) ≥50% of the time. * Relapse-free for the past 30 days. * Godin Leisure Time Exercise Questionnaire Health Contribution Score \<14 units (i.e., not meeting current physical activity guidelines). Exclusion Criteria: * An MS relapse within the past 30 days
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Multiple sclerosis are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
The University of Texas Health Science Center at Houston
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily versus intermittent incremental vestibulo-ocular reflex adaptation as a novel treatment for dizziness in people with multiple sclerosis
- Intravoxel incoherent motion (IVIM) magnetic resonance imaging in multiple sclerosis
- Assessment of serum neurofilament-light chain (NfL) and glial fibrillary acidic protein (GFAP) levels, atrophy of the macular ganglion cell complex (GCC) by optical coherence tomography (OCT) and whole brain atrophy by MRI to predict evolution of neurological disability in multiple sclerosis patients
- Hand grip strength correlates strongly with weekly working hours - the importance of upper limb function in multiple sclerosis
- Serum neurofilament-light chain and glial fibrillary acidic proten (GFAP) levels in patients from the OFSEP cohort at different landmarks of multiple sclerosis
- Can donated umbilical cord stem cells calm multiple sclerosis?